Page 25 - aruba-today-20170308
P. 25

BUSINESS A25
                                                                                                                                   Wednesday 8 March 2017

Drugmakers fall as investors see pricing threat from Trump 

MARLEY JAY                     A pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sac-                                       and since Trump’s elec-
LINDA A. JOHNSON               ramento, Calif. Up went the tweet, and down went drug company stocks. Just before the stock                                       tion. They’ve proposed let-
AP Business Writers            market opened on Tuesday, President Donald Trump said he is working on “a new system” to                                          ting patients import medi-
NEW YORK (AP) — Up went        reduce prices.                                                                                                                    cines from Canada, where
the tweet, and down went                                                                                                                                         government price controls
drug company stocks.                                                                                                                (AP Photo/Rich Pedroncelli)  keep costs much lower,
Just before the stock mar-                                                                                                                                       and allowing the federal
ket opened on Tuesday,         “We certainly lack the un-      Some of the biggest loss-      maceuticals, also traded                                           Medicare plan to negoti-
President Donald Trump         derstanding of what he          es Tuesday went to bio-        lower. Several generic                                             ate prices for the drugs it
said he is working on “a       wants to do,” said Les Funt-    technology companies,          drugmakers are under                                               buys for seniors.
new system” to reduce          leyder, health care portfo-     which make drugs that are      scrutiny over allegations                                          But bills containing those
prices. He also said he’ll     lio manager for E Squared       complicated to engineer        of price-fixing. Democrats                                         ideas haven’t gone any-
bring “competition” to the     Asset Management. “He           and can be extremely ex-       and a few Republicans in                                           where. That’s mainly be-
drug industry. It’s not the    keeps making conflicting        pensive. Companies that        Congress have some ideas                                           cause of opposition from
first time comments from       statements it’s hard to re-     make generic drugs, gen-       that are aimed at reining                                          Congressional Republi-
Trump have had a big ef-       ally pin him down.”             erally the least costly phar-  in drug prices, both before                                        cans and pressure from the
fect on pharmaceutical                                                                                                                                           pharmaceutical industry,
stocks: he hasn’t gotten                                                                                                                                         which is among the top
into specifics and investors                                                                                                                                     spenders on lobbying Con-
aren’t sure how committed                                                                                                                                        gress.
he is to doing something.                                                                                                                                        Top drugmakers have ar-
In January Trump accused                                                                                                                                         gued for years that any
drugmakers of “getting                                                                                                                                           type of price controls
away with murder” on drug                                                                                                                                        would crimp innovation
prices, and pharmaceuti-                                                                                                                                         because research is so ex-
cal and biotech stocks fell                                                                                                                                      pensive. Their trade groups
sharply. Less than three                                                                                                                                         are running tear-jerker ad
weeks later, he held an ap-                                                                                                                                      campaigns touting how
parently friendly sit-down                                                                                                                                       new drugs help patients
with industry executives at                                                                                                                                      with awful diseases.
the White House and said                                                                                                                                         Patients and politicians
he wants to speed up the                                                                                                                                         have blasted drugmakers
drug approval process,                                                                                                                                           over soaring drug prices
which could bring costs                                                                                                                                          in the past, but this round
down for drug companies.                                                                                                                                         of criticism is more intense
The stocks moved higher                                                                                                                                          and it has lasted almost
afterward.                                                                                                                                                       two years. q

Saudi energy minister keeping close eye on US oil producers 

AP Business Writer             much of the OPEC cuts by        producers, like non-OPEC       Tuesday, while the global                                          worse shape economical-
HOUSTON (AP) — Saudi           pumping oil from shale for-     Russia, have fallen short.     benchmark traded just                                              ly, the Saudis too feel the
Arabia’s energy minister       mations, al-Falih says he is    “Some have not lived up to     above $56. Saudi Arabia                                            pinch. The kingdom needs
says OPEC production           watching the U.S. produc-       expectations,” al-Falih said,  is the world’s biggest pro-                                        the money to pay for social
cuts are working to bolster    ers closely. OPEC, whose        “but as a whole if you look    ducer and is carrying the                                          programs, raising questions
crude prices and his coun-     members account for             at the totality the agree-     heaviest load of produc-                                           about how long and how
try will look at whether       about one-third of global       ment is working well.”         tion cuts. While other OPEC                                        low it will go with produc-
other oil-producing nations    oil output, agreed to cut       Oil prices have stabilized     members such as Venezu-                                            tion cuts, which expire in
are living up to their prom-   production beginning in         above $50 a barrel — a         ela and Nigeria are in far                                         July.q
ises to curtail pumping be-    January by 1.2 million bar-     rebound from early 2016,
fore deciding whether to       rels a day. Other countries     when they plunged below
extend the cutbacks be-        joined in, pushing the total    $30 a barrel — although
yond this summer. Khalid       to nearly 1.8 million barrels.  some analysts had expect-
al-Falih expressed no great    By independent accounts,        ed closer to $60. The U.S.
alarm Tuesday about the        those targets have mostly       benchmark traded around
recovery in American oil       been met, although some         $53.30 a barrel at midday
output since crude prices
began rebounding in early
2016, although he indicat-
ed surprise at how quickly it
bounced back. The Energy
Department said Tuesday
that U.S. production aver-
aged 8.9 million barrels a
day last year, and it fore-
cast increases to 9.2 million
barrels a day this year and
9.7 million — a possible re-
cord — in 2018. In a nod to
America’s ability to offset
   20   21   22   23   24   25   26   27   28   29   30